The goal is to draw researchers’ attention to this dark ... it possible to systematically study their effects in cells: CRISPR–Cas9 gene editing. “Suddenly we could surgically take out ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

In the spring, five patients with sickle cell disease began treatment with Casgevy, the first FDA-approved CRISPR-Cas9 gene editing treatment. The therapy—which involves removing blood stem ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

A UCO team has applied the genome editing technique, which garnered a Nobel Prize in Chemistry in 2020, to unravel the functions of two genes involved in the metabolism of beans and that could not be ...

Scientists at Argentine biotech firm Kheiron have produced the world’s first genetically edited horses using a technique called CRISPR-Cas9. The horses were born last October and November.

CRISPR technology has revolutionized genetic testing and disease detection, offering precise, rapid, and cost-effective diagnostic solutions. This gene-editing tool has been adapted for molecular ...

CRISPR Therapeutics AG (CRSP) closed at $43.42 in the latest trading session, marking a -1.83% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.29%.